fda bpc 157 category 2 bulk drug substance compounding list Exciting news for peptides coming out of today's committee hearing! The Pharmacy Advisory Committee voted 8-6 to recommend adding BPC- to the 503A Bulks for use in compounding for The experts will take votes

The experts will take votes on whether the FDA should allow seven popular peptides to be added to a list of substances that are safe for compounding by pharmacies. Big news for peptides! In July, the FDA will meet to evaluate the most commonly used peptides for FDA authorized compounding. Repost @peptides with @use.repost BREAKING NEWS! Today's 86 advisory vote for BPC 157 is one of the biggest peptide regulatory developments we've seen in years. While nothing changes immediately, the recommendation represents FDA's own advisory committee voted 8 6 Thursday. BPC 157, on the compounding list now, for ulcerative colitis. FDA staff argued against it, laid out the data gaps, the whole case. Panel overruled them FDA advisers back first four of seven unapproved peptides under review for looser rules Reuters

SKU: 36843168993 · From metron-ms.com